Digital Health Obesity Market Size and Share - Growth Analysis Report and Forecast Trends 2026-2030

The digital health for obesity market encompasses technology-driven products and services designed to prevent, manage, and treat obesity, including mobile apps, connected wearables, telehealth platforms, remote patient monitoring systems, and digital therapeutics paired with pharmacological treatments. Market estimates for 2025 range from approximately $57 billion to $73 billion across research firms, with an average convergence around $72 billion, while projected compound annual growth rates fall between 21.4% and 24.6% through the early 2030s. Government agencies such as the World Health Organization and the U.S. Centers for Disease Control and Prevention publish epidemiological data on obesity prevalence, but they do not produce commercial market-size metrics, leaving financial valuations to private research organizations.

• •Market size estimates for 2025 vary by research firm, typically falling between $57 billion and $73 billion
• •Projected CAGR through the early 2030s ranges from approximately 21.4% to 24.6% depending on the forecast model
• •Official health agencies track obesity prevalence data but do not publish financial market-size figures for digital health obesity solutions

Rising global obesity rates have created urgent demand for scalable, cost-effective interventions, with the World Health Organization estimating over 1 billion people worldwide living with obesity as of the early 2020s. Advances in mobile health platforms, artificial intelligence-driven coaching, continuous glucose monitors, and GLP-1 receptor agonist therapies have converged to create more integrated and effective digital treatment pathways. Payers and healthcare systems are increasingly recognizing the long-term cost savings of digital obesity management, leading to expanded reimbursement coverage and employer-sponsored wellness program adoption.

• •Global obesity prevalence exceeding 1 billion people has intensified demand for accessible, technology-enabled weight management tools
• •Integration of digital platforms with pharmaceutical therapies, particularly GLP-1 drugs, has accelerated market expansion
• •Growing reimbursement coverage by insurers and employers has reduced patient out-of-pocket costs and broadened market access

The market is commonly segmented by solution type, including apps and software platforms, connected devices and wearables, telehealth and virtual care services, and digital therapeutics often combined with clinical interventions. Geographically, North America leads in market share due to high obesity prevalence, advanced healthcare infrastructure, and favorable reimbursement environments, while Europe and Asia-Pacific represent rapidly growing regions driven by increasing health awareness and expanding digital health adoption. Emerging markets in Latin America, the Middle East, and Africa are beginning to contribute to growth as mobile penetration rises and healthcare systems modernize.

• •Key segments include mobile applications, connected wearables, telehealth platforms, and digital therapeutics with clinical oversight
• •North America holds the largest regional share, supported by high obesity rates and established digital health infrastructure
• •Asia-Pacific and Europe are the fastest-growing regions, driven by rising health consciousness and expanding digital adoption

What are the recent trends and outlook?

Artificial intelligence and machine learning are increasingly embedded in digital obesity platforms to deliver personalized interventions, predictive analytics, and adaptive coaching tailored to individual patient profiles. Regulatory frameworks for digital therapeutics and software as a medical device are maturing, particularly in the United States and European Union, which is expected to accelerate product approvals and clinical validation. Over the forecast horizon, deeper integration between digital platforms, electronic health records, and healthcare provider workflows is likely to drive greater clinical adoption and sustained market growth.

• •Artificial intelligence and machine learning are enabling personalized, adaptive obesity management programs that adjust to individual user behavior and outcomes
• •Regulatory pathways for digital therapeutics are becoming clearer, particularly FDA and CE mark frameworks for software as a medical device
• •Long-term market growth is expected to be reinforced by integration of digital health platforms with clinical care systems and electronic health records